In the USA, Canada, and Australia, the recorded incidence increased rapidly in the late 1980s and early 1990s because of the widespread introduction of PSA testing, which allowed for early detection of prostate cancers, including clinically insignificant cases that would otherwise not have been diagnosed. The gene discussed is KLK3; the disease is prostate carcinoma.